Cooper Companies to acquire Sauflon, CooperVision partners with Turkish university

Article

The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

Pleasanton, CA-The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

The transaction is subject to regulatory approval and is anticipated to close prior to the company’s fiscal year end, October 31, 2014.

“We are extremely pleased to announce this acquisition which gives CooperVision the world's most comprehensive portfolio of daily disposable lenses,” says Robert S. Weiss, Cooper's president and chief executive officer. “CooperVision will now be able to offer a multi-tier daily strategy that includes a full suite of silicone hydrogel and hydrogel lenses, including options within all categories-spheres, torics, and multifocals. The daily segment is the fastest growing segment of the soft contact lens market and this transaction positions CooperVision as the premier company in this space.”

In related news, CooperVision recently partnered with Bogazici University’s College of Business in Istanbul, Turkey, to focus on developing its next generation of global leaders. As a component of the company’s Inspirational Leadership Program, a select group of senior leaders spent five days on campus earlier this year, immersing themselves in issues relating to entrepreneurship, governance, national culture and institutions, financial management and growing a high-caliber, emerging market workforce.

Bogazici University is ranked among the world’s top 200 institutions of higher education. Its dynamic faculty is internationally respected and globally connected, and highly able to share experiences and insights regarding the dynamic and sometimes volatile nature of multinational business challenges and opportunities.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.